Lymphovascular invasion is an independent prognostic factor for survival in pathologically proven N2 non-small cell lung cancer. Swiss Medical Weekly, [S. l.], v. 151, n. 0506, p. w20385, 2021. DOI: 10.4414/smw.2021.20385. Disponível em: https://smw.ch/index.php/smw/article/view/2948. Acesso em: 19 oct. 2025.